NR4A2 and autoimmune disease: This increase in NR4A2 expression by autoimmune T cells was not observed in the STZ model of autoimmune diabetes, which is mediated by Th1 cells, suggesting that the enhanced expression of NR4A2 is associated with autoimmune diseases where IL-17 plays a pathogenic role (115).